|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.48 USD | +1.49% |
|
-0.68% | -13.80% |
| Mar. 06 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
| Mar. 06 | QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel | MT |
Company Valuation: Qiagen N.V.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,655 | 12,018 | 12,618 | 11,355 | 9,910 | 8,532 | 8,532 | - |
| Change | - | 56.99% | 4.99% | -10.01% | -12.73% | -13.9% | 0% | - |
| Enterprise Value (EV) 1 | 8,608 | 13,226 | 13,495 | 12,529 | 10,362 | 10,136 | 8,805 | 8,251 |
| Change | - | 53.64% | 2.03% | -7.15% | -17.3% | -2.18% | -2.05% | -6.29% |
| P/E ratio | -188x | 34.5x | 25.1x | 27.1x | 30.3x | 124x | 20.1x | 17.7x |
| PBR | 3.08x | 4.31x | 4.08x | 3.28x | 2.71x | 2.89x | 2.28x | 2.05x |
| PEG | - | -0x | 0.6x | -1.6x | -1.4x | -1.6x | 0x | 1.3x |
| Capitalization / Revenue | 5.02x | 6.43x | 5.6x | 5.3x | 5.04x | 5x | 4.18x | 3.92x |
| EV / Revenue | 5.64x | 7.07x | 5.99x | 5.85x | 5.27x | 5.12x | 4.31x | 3.79x |
| EV / EBITDA | 15.6x | 17.7x | 15.3x | 15.9x | 15.7x | 14.4x | 11.5x | 9.99x |
| EV / EBIT | 20.4x | 21.1x | 17.9x | 19.1x | 19.6x | 17.9x | 14.6x | 12.6x |
| EV / FCF | 40.4x | 40.7x | 30x | 21.4x | 33.5x | 20x | 17.6x | 15.6x |
| FCF Yield | 2.47% | 2.46% | 3.33% | 4.68% | 2.99% | 5% | 5.67% | 6.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.1909 | 1.622 | 2.343 | 1.951 | 1.522 | 0.37 | 1.967 | 2.227 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,526 | 1,870 | 2,252 | 2,142 | 1,965 | 1,978 | 2,041 | 2,177 |
| EBITDA 1 | 551.8 | 747.8 | 884.2 | 789.7 | 659 | 702.2 | 763.4 | 825.8 |
| EBIT 1 | 421.8 | 626.8 | 755 | 656.3 | 528.6 | 567 | 604.9 | 654.7 |
| Net income 1 | -41.46 | 359.2 | 512.6 | 423.2 | 341.3 | 83.59 | 427.7 | 481.4 |
| Net Debt 1 | 953.1 | 1,208 | 876.5 | 1,174 | 452 | 238.6 | 272.3 | -281.2 |
| Reference price 2 | 35.84 | 56.04 | 58.94 | 52.88 | 46.05 | 39.48 | 39.48 | 39.48 |
| Nbr of stocks (in thousands) | 213,589 | 214,454 | 214,097 | 214,734 | 215,189 | 216,116 | 216,116 | - |
| Announcement Date | 2/4/20 | 2/9/21 | 2/8/22 | 2/10/23 | 2/6/24 | 2/5/25 | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E ratio (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 51.89x | 4.54x | 12.29x | -.--% | 8.53B | ||
| 47.17x | 6.47x | 22.98x | 0.82% | 44.77B | ||
| 24.05x | 2.8x | 11.67x | -.--% | 32.65B | ||
| 96.09x | 11.8x | 43.13x | 0.24% | 27.52B | ||
| 17.89x | 2.06x | 10.24x | -.--% | 14.91B | ||
| 11.27x | 3.4x | 6.48x | -.--% | 13.8B | ||
| -3.38x | 4.16x | -2.3x | -.--% | 13.38B | ||
| 26.23x | 4.32x | 19.46x | -.--% | 9.9B | ||
| 52.38x | 7.95x | 22.96x | 0.51% | 9.83B | ||
| -40.45x | 15.77x | -40.6x | -.--% | 9.15B | ||
| Average | 28.31x | 6.33x | 10.63x | 0.16% | 18.44B | |
| Weighted average by Cap. | 36.68x | 6.20x | 16.04x | 0.26% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- QGEN Stock
- Valuation Qiagen N.V.